The Current Ratio as of December 2025 (TTM) for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) is 1.89

According to Biocytogen Pharmaceuticals (Beijing) Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.89. This represents a change of 25.79% compared to the average of 1.50 of the last 4 quarters.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Historical Current Ratio (quarterly & annually)

How has 2315.HK Current Ratio performed in the past?

The mean historical Current Ratio of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. over the last ten years is 1.95. The current 1.89 Current Ratio has changed 9.59% with respect to the historical average. Over the past ten years (40 quarters), 2315.HK's Current Ratio was at its highest in in the December 2021 quarter at 1.96. The Current Ratio was at its lowest in in the June 2021 quarter at 0.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Average Current Ratio

How has 2315.HK Current Ratio performed in the past?

The current Current Ratio of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Current Ratio vs. Peers

How is 2315.HK’s Current Ratio compared to its peers?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.’s Current Ratio is less than Alphamab Oncology (4.98), less than Shanghai Haohai Biological Technology Co., Ltd. (3.77), greater than Lepu Biopharma Co., Ltd. (0.63), less than Nanjing Leads Biolabs Co Ltd (0), less than HBM Holdings Limited (6.05), less than Abbisko Cayman Limited (11.59), less than Angelalign Technology Inc. (2.78), less than CARsgen Therapeutics Holdings Limited (6.45), less than Beijing Chunlizhengda Medical Instruments Co., Ltd. (6.33), less than Ascletis Pharma Inc. (14.57),

Build a custom stock screener for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocytogen Pharmaceuticals (Beijing) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biocytogen Pharmaceuticals (Beijing) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.